Taiwan FDA registration 81a8c6ab87add721e4d04ecaa5912294
"Termao" Spistrong Aputia blood cell separator
TW: “泰爾茂”思倍壯亞普緹亞血液細胞分離機
Taiwan·Risk Class 2·TERUMO BCT, INC.·Registered Mar 15, 2010 – Mar 15, 2030ActiveRegistration details
- Analysis ID
- 81a8c6ab87add721e4d04ecaa5912294
- Customs Code
- DHA00602067004
Company information
- Manufacturer
- TERUMO BCT, INC.
- Manufacturer Country
- United States
- Authorized Representative
- TERUMO TAIWAN MEDICAL CO., LTD.
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.9245 Automated hemocytoseparator
- Import Information
- import
Dates and status
- Registration Date
- Mar 15, 2010
- Expiry Date
- Mar 15, 2030
About this record
Access comprehensive regulatory information for "Termao" Spistrong Aputia blood cell separator in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 81a8c6ab87add721e4d04ecaa5912294 and manufactured by TERUMO BCT, INC.. The authorized representative in Taiwan is TERUMO TAIWAN MEDICAL CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices